Stock Rating Upgrade
The Value Trend Rating for Neogenomics Inc (NASDAQ: NEO) improved in recent days from D to C reflecting improving fundamentals and high Appreciation Potential. Details supporting this higher rating are included in our next report.
Recent Price Action
On 9/20/24, Neogenomics Inc (NASDAQ: NEO) stock declined modestly by -1.2%, closing at $16.28. Moreover, trading volume in this decline was exceptionally high at 254% of normal. The stock has performed in line with the market over the last nine months and is unchanged during the last week.
Current PriceTarget Research Rating
Reflecting future returns on capital that are forecasted to be in line with the cost of capital, NEO is expected to continue to be Value Creation neutral.
Neogenomics has a current Value Trend Rating of C (Low Neutral). This VT Rating improved in recent days from D previously. The Value Trend Rating reflects contradictory signals from PTR’s two proprietary measures of a stock’s attractiveness. Neogenomics has a poor Appreciation Score of 25 but a slightly positive Power Rating of 66, resulting in the Low Neutral Value Trend Rating.
Be the first to comment